Clinical Trial Update: CardiAMP™ Cell Therapy for Heart Failure Trial [Phase 3]

View source ↗

Summary

BioCardia's CardiAMP cell therapy Phase 3 trial for systolic heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• CardiAMP

Snippet

Sponsor: BioCardia, Inc. | Conditions: Heart Failure, Systolic | Phase 3 | Status: COMPLETED